Baidu
map

Ann Rehabil Med:护理者是否能很好照顾卒中患者的调查

2015-12-03 phylis 译 MedSci原创

目标:调查多少正式的护理者知道怎样照顾卒中患者,并且调查他们是否能充分照顾。方法:共有8家医院(4所大学医院,2所康复医院,2疗养医院)的卒中患者的正式照顾者参与这项研究。调查基于自我报告问卷,这个问卷包括关于具体照顾卒中患者的6类48个问题:照顾者的人口学资料,床的定位,膳食提供,位置变化和转移,运动训练的范围及照顾者训练。结果:对217名照顾者进行了调查,分布如下:41%来自大学医院,35%来

目标:调查有多少正式的护理者知道怎样照顾卒中患者,并且调查他们是否能充分照顾。

方法:共有8家医院(4所大学医院、2所康复医院、2疗养医院)的卒中患者的正式照顾者参与了这项研究。调查基于自我报告问卷,这个问卷包括关于具体照顾卒中患者的6类共48个问题:照顾者的人口学资料、床的定位、膳食提供、位置变化和转移、运动训练的范围及照顾者训练。

结果:对217名照顾者进行了调查,分布如下:41%来自大学医院,35%来自康复医院,24%来自疗养医院。正确答案的百分比分布如下:64.3%床的定位,74.3%膳食提供和62.4%的位置变化和转移。在疗养医院的照顾者全量表得分显著低于其他类型的护理者的得分。只有7.8%的受试者接受定期培训。照顾者从照顾者协会获得的大部分信息(58.1%),并且大多数的照顾者(65.4%)愿意接受培训。

结论:约三分之一(33.8%)的照顾者对如何妥善照顾卒中患者,没有足够的知识;事实上,大多数照顾者在许多方面的知识是不适当,不充分的。由康复专家提供定期培训,将改善护理者的专业知识并积极影响患者预后。

原文出处:

Lee KW, Choi SJ, Kim SB, et al. A Survey of Caregivers' Knowledge About Caring for Stroke Patients. Ann Rehabil Med. 2015 Oct.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1720081, encodeId=4dc11e20081be, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Jan 29 23:10:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48958, encodeId=884d48958fb, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 08:40:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48959, encodeId=ce9e48959ac, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 08:40:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521853, encodeId=9d3e1521853b4, content=<a href='/topic/show?id=f83866137f' target=_blank style='color:#2F92EE;'>#EHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6613, encryptionId=f83866137f, topicName=EHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937d11405368, createdName=qjddjq, createdTime=Sat Dec 05 11:10:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606747, encodeId=54531606e47f9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Dec 05 11:10:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44737, encodeId=a38944e37a1, content=加强教育, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 04 12:19:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1720081, encodeId=4dc11e20081be, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Jan 29 23:10:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48958, encodeId=884d48958fb, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 08:40:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48959, encodeId=ce9e48959ac, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 08:40:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521853, encodeId=9d3e1521853b4, content=<a href='/topic/show?id=f83866137f' target=_blank style='color:#2F92EE;'>#EHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6613, encryptionId=f83866137f, topicName=EHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937d11405368, createdName=qjddjq, createdTime=Sat Dec 05 11:10:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606747, encodeId=54531606e47f9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Dec 05 11:10:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44737, encodeId=a38944e37a1, content=加强教育, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 04 12:19:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2015-12-27 hixiaoluo

    好文章,值得收藏

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1720081, encodeId=4dc11e20081be, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Jan 29 23:10:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48958, encodeId=884d48958fb, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 08:40:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48959, encodeId=ce9e48959ac, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 08:40:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521853, encodeId=9d3e1521853b4, content=<a href='/topic/show?id=f83866137f' target=_blank style='color:#2F92EE;'>#EHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6613, encryptionId=f83866137f, topicName=EHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937d11405368, createdName=qjddjq, createdTime=Sat Dec 05 11:10:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606747, encodeId=54531606e47f9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Dec 05 11:10:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44737, encodeId=a38944e37a1, content=加强教育, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 04 12:19:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2015-12-27 hixiaoluo

    好文章,值得收藏

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1720081, encodeId=4dc11e20081be, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Jan 29 23:10:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48958, encodeId=884d48958fb, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 08:40:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48959, encodeId=ce9e48959ac, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 08:40:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521853, encodeId=9d3e1521853b4, content=<a href='/topic/show?id=f83866137f' target=_blank style='color:#2F92EE;'>#EHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6613, encryptionId=f83866137f, topicName=EHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937d11405368, createdName=qjddjq, createdTime=Sat Dec 05 11:10:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606747, encodeId=54531606e47f9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Dec 05 11:10:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44737, encodeId=a38944e37a1, content=加强教育, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 04 12:19:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2015-12-05 qjddjq
  5. [GetPortalCommentsPageByObjectIdResponse(id=1720081, encodeId=4dc11e20081be, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Jan 29 23:10:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48958, encodeId=884d48958fb, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 08:40:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48959, encodeId=ce9e48959ac, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 08:40:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521853, encodeId=9d3e1521853b4, content=<a href='/topic/show?id=f83866137f' target=_blank style='color:#2F92EE;'>#EHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6613, encryptionId=f83866137f, topicName=EHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937d11405368, createdName=qjddjq, createdTime=Sat Dec 05 11:10:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606747, encodeId=54531606e47f9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Dec 05 11:10:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44737, encodeId=a38944e37a1, content=加强教育, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 04 12:19:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1720081, encodeId=4dc11e20081be, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Jan 29 23:10:00 CST 2016, time=2016-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48958, encodeId=884d48958fb, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 08:40:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48959, encodeId=ce9e48959ac, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 08:40:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521853, encodeId=9d3e1521853b4, content=<a href='/topic/show?id=f83866137f' target=_blank style='color:#2F92EE;'>#EHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6613, encryptionId=f83866137f, topicName=EHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937d11405368, createdName=qjddjq, createdTime=Sat Dec 05 11:10:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606747, encodeId=54531606e47f9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Dec 05 11:10:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44737, encodeId=a38944e37a1, content=加强教育, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Fri Dec 04 12:19:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2015-12-04 老段

    加强教育

    0

相关资讯

RSNA 2015:3D MRI技术或可改善糖尿病患者卒中风险的预测

新研究表明,使用3D MRI评估2型糖尿病患者颈动脉斑块内出血情况可以估计患者中风风险。斑块内出血是动脉粥样硬化疾病的一项指标,即使没有被发现颈动脉狭窄也可能发现斑块内出血。多伦多新宁研究所的Tishan Maraj在2015年北美放射学年会上对其发现进行了汇报。Dr Maraj和团队重点放在了糖尿病患者身上,因为糖尿病是卒中后预后不良的危险因素,且死亡风险明显增加。糖尿病是全球健康负担,预防并发

BMJ Open:卒中后1年花费及患者生活质量的调查

目标:评估和探索卒中后1年(1)社会花费(2)花费及生活质量(QoL)的改变(3)花费和生活质量之间的关系。设计:目前主要研究卒中后的花费及QoL设置:医院卒中单元的卒中患者,并对其随访1年。参与者:395例脑卒中患者。主要预后指标:花费及QoL方法:花费分类由自低向上的方法确定。应用荷兰-三维5维度欧洲QoL计算QoL。应用非参数逐步法计算花费的统计差异。亚组分析识别花费和QoL的预测因子。通过

Stroke:卒中早期、晚期再发率及预测因子研究(NDPSS研究)

背景和目的:最近几项研究应用前瞻性基于人群的方法学,调查了早期和晚期卒中再发率及预测因子。研究者调查了北都柏林人群卒中研究(NDPSS)中2年内卒中再发。方法:2005年12月到2006年间,招募了社区和医院的患者。确定患者72小时、7天、28天、90天、1年、2年,脑卒中复发、生存期及功能性预后。结果:567例患者中,累计2年卒中复发率为10.8%,病死率为38.6%。复发卒中亚型与初发卒中亚型

Stroke:卒中位置是认知预后的独立预测因子

背景和目的:准确预测脑卒中患者认知预后是对临床管理有重要的影响。研究者调查卒中部位是否可预测多因素预测模型中的功能和认知预后。方法:共有428名缺血性卒中患者,在卒中发生24到72h内对其进行MRI检测,3个月时,应用mRS评估患者功能预后,应用蒙特利尔认知评估量表(MoCA)评估认知预后。从第一批患者(215名),获得功能和认知功能区的统计地图。研究者应用多变量回归模型研究卒中区域,年龄,基线N

J Am Heart Assoc:实现“简单生活方式7”可延长卒中后生存时间

背景:美国心脏病协会制定被称为“简单生活7” 的标准,定义理想的心血管健康:不吸烟,规律体育运动,健康饮食,保持正常体重,控制胆固醇,血压和血糖水平。实现这些目标对卒中后生存的影响尚不清楚。研究者旨在确定美国卒中幸存者心血管健康分数及评估心血管健康分数及卒中后各种原因的死亡率。方法和结果:研究者评估美国成年人全国代表性的卒中患者的心血管健康分数(n = 420),这些患者参加了1988-1994年

BMC Neurol:心理社会应激是卒中发生的危险因素(meta分析)

背景:许多研究表明心理社会应激与卒中发生的风险增加,然而,有关知觉应激的定义和检测方法不同,研究设计的不同,研究实施及获得的结论不同,最后的结果也不一致,尚未有相关的meta分析发表。研究者旨在进行一项系统性综述及meta分析评估心理社会应激与卒中发生的相关性。方法:系统搜索MEDLINE,EMBASE,CINAHL,PsycINFO,和Cochrane系统评价数据库中发表在1980年到2014年

Baidu
map
Baidu
map
Baidu
map